Dermatan sulfate-low molecular weight - Mediolanum

Drug Profile

Dermatan sulfate-low molecular weight - Mediolanum

Alternative Names: MF 777

Latest Information Update: 28 May 2007

Price : $50

At a glance

  • Originator Mediolanum
  • Class Antithrombotics
  • Mechanism of Action Glycosaminoglycan stimulants; Thrombin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Venous thrombosis

Most Recent Events

  • 28 Mar 2000 Preclinical development for Venous thrombosis in Italy (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top